- Why is FDA recommending that Paxil not be used for 
        the treatment of pediatric major depressive disorder (MDD)? 
 
        FDA is currently reviewing reports of an increased risk of suicidal 
        thinking and suicide attempts related to the use of the drug Paxil in 
        children and adolescents under the age of 18 with MDD. Although FDA has 
        not completed this evaluation, we are recommending that Paxil not be 
        used in the treatment of pediatric MDD. There is no evidence that Paxil 
        is effective in children or adolescents with MDD.
        - Should children using Paxil stop taking it 
        immediately? 
 
        It is very important that children and adolescents not 
        stop taking Paxil suddenly, as there is a risk of discontinuation 
        effects. Caretakers of children and adolescents currently taking Paxil 
        should consult their doctor to discuss the best course of action. If 
        they are doing well on Paxil, their doctor may advise that they complete 
        their course of treatment. If their doctor advises that Paxil should be 
        stopped, this should be done gradually to minimize the risk of 
        discontinuation effects. If the dose is not reduced gradually, there is 
        a greater chance of experiencing side effects. If severe unwanted side 
        effects occur, it may be necessary to start taking Paxil again or 
        increase the dose before subsequently decreasing the dose more 
        gradually.
        - What data is the advice based on? 
 
        Three well-controlled clinical trials carried out in children (under 
        18 years of age) with MDD compared the effect of Paxil and placebo 
        (sugar pills) and found that Paxil did not work any better than placebo 
        in the treatment of MDD.
        Based on the results of the new analyses of safety data from 
        pediatric studies, it was found that certain possibly suicide-related 
        behaviors, including suicidal thoughts and attempts, were more common in 
        children receiving Paxil. The risk of these events in the study was 
        about 3 times greater with Paxil compared to placebo. There were no 
        deaths in these trials.
        - Is Paxil approved for the treatment of children and 
        adolescents? 
 
        The FDA has not approved Paxil for the treatment of MDD or any other 
        indication in pediatric patients. However, the FDA does not regulate the 
        practice of medicine and physicians may use a drug in ways other than 
        indicated on the labeling when, in their professional judgment, it is 
        warranted in a particular case.
        - My child is taking Paxil for a condition other than 
        depression. What should I do? 
 
        Paxil has not been approved for use in children under the age 
        of 18 for any indication, but your child may have been prescribed Paxil 
        for an off-label use. As stated above, physicians may use a drug in ways 
        other than indicated on the labeling when, in their professional 
        judgment, it is warranted in a particular case. If your child is taking 
        Paxil, you should consult with your doctor before making any changes. It 
        is very important that Paxil not be stopped abruptly since 
        discontinuation effects may occur.
        - What does this mean for the use of Paxil in adults? 
        
 
        Paxil is approved for use in adults for the following indications: 
        major depressive disorder, obsessive compulsive disorder, panic 
        disorder, social anxiety disorder, generalized anxiety disorder, and 
        post-traumatic stress disorder. Extensive analyses of the data from 
        studies of Paxil in adults and from postmarketing adverse event reports 
        have not revealed an increase in the rate of suicidal thoughts or 
        suicide attempts compared to placebo.
        - What advice can you provide to adults using Paxil? 
        
 
        It is vital that patients are not panicked into stopping their 
        medication suddenly. The advice to adults using Paxil has not changed. 
        Paxil has been demonstrated to be effective in treatment of major 
        depressive disorder, obsessive compulsive disorder, panic disorder, 
        social anxiety disorder, generalized anxiety disorder, and 
        post-traumatic stress disorder in adults. Anyone taking Paxil who is 
        feeling unwell or is concerned about the treatment should consult his 
        or her doctor.
        - Why would Paxil cause these reactions in children and 
        not in adults? 
 
        Childhood depression is different from adult depression. The 
        reasons are not clear but could relate to the continuing development of 
        the child’s brain. It has been difficult to show effectiveness in 
        children of antidepressants known to work in adults and a number of 
        effective adult antidepressants have not been shown to work in 
        childhood depression Children may also react very differently to 
        some medicines and some side effects over a range of drugs are seen in 
        children that are not seen in adults.
        However, the Agency has not yet definitively determined that there is 
        an increased risk of suicidal behavior in pediatric patients with MDD 
        treated with Paxil.
        - Are there drugs approved for the treatment of 
        depression in children? 
 
        Prozac (fluoxetine) is the only drug approved for the treatment of 
        major depressive disorder in children. It is approved in children 8 to 
        18 years of age.
        - What is Paxil? 
 
        Paxil (paroxetine) is one of a class of medicines called Selective 
        Serotonin Reuptake Inhibitors (SSRIs). These drugs increase the activity 
        of an important brain chemical called serotonin, a chemical know to be 
        deficient in patients with MDD.
        - How long has Paxil been on the market? 
 
        Paxil was first approved in the United States on December 29, 1992, 
        for the treatment of depression.